Advances in dementia diagnosis have significantly improved early detection and precision. Early indicators of neurodegeneration can be found with the help of neuroimaging techniques such as MRI and PET scans, which provide crucial information about the structure and function of the brain. Biomarkers, such as tau and amyloid beta proteins, can be found in blood or cerebrospinal fluid to monitor the course of a disease. Cognitive testing and neuropsychological examinations also aid in identifying certain deficiencies and assessing cognitive capacities. Combining these methods allows medical professionals to identify patients more accurately and implement interventions early, which may help halt the disease's course.
Track 18-1: Atypical Presentations
Track 18-2: Novel Treatment Approaches
Track 18-3: Case Series
Track 18-4: Case Reports in Specific Subtypes of Dementia
Track 18-5: Case Reports in Special Populations
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
